RE:RE:CXR is down becuase
I'm amused at these types of threads by people who know little about the pharma world beyond the media hype. I'll address a few points below as time is valuable:
1) CEO pay is driven by performance. Go look at the SP from 2013 when they started to where they are (even today) and I doubt anyone would argue with whats been accomplished.
2) VRX and CXR do have a publicity problem but so do all pharma. There is a BIG difference as many of us know regarding their strategies. CXR buys products and inreases volumes whereas VRX buys companies and cuts costs / raises prices.
3) It'll take a few quarters but once management starts showing ability to pay down debt without a problem, this is all the market wants to hear. No amount of PR will replace this. Will the stock move until that confidence is obtained, for sure. To comment on a daily basis when there has been NO NEWS on CXR, is just a waste of time and effort. Those that do it have nothing better than to bash on SH boards.
Waiting for the one star bashers :)